[1] [2] Using improperly stored GLP-1 medication may result in inadequate glycemic control for patients with type 2 diabetes, potentially leading to hyperglycemia
[55] demonstrated that dietary variables contribute significantly to fatalities from heart disease, stroke, and T2D
Its biggest weakness is medical oversight, lab requirements vary, compounded drugs raise quality concerns, and limited coaching reduces long-term success
PubMed laboratory research record [PMID: 16227137] PubMed record related to this compound for laboratory literature review
However, a slight increase in OCD risk was observed, and no significant associations were identified for broad depression, major depressive disorder, anorexia nervosa, or self-harm
Between June and July 2025, when the formulary change was implemented, switching from AOM tirzepatide increased, while patients with an active supply of AOM semaglutide showed stable or even slightly reduced switching during the same period, consistent with its designation as the preferred option